A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
Atrial fibrillation (AF) is a common arrhythmia in patients with type 2 diabetes (T2D). Patients with diabetes are at higher risk of AF than those without it. There is an increased risk of dysglycemia in AF. Patients with AF and concomitant diabetes are more likely to have coronary artery disease, h...
Main Authors: | A. G. Obrezan, A. E. Filippov, A. A. Obrezan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2021-06-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4508 |
Similar Items
-
Trend of Prevalence of Atrial Fibrillation and use of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation in South Korea (2002–2013)
by: Mi Kyoung Son, et al.
Published: (2018-02-01) -
Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
by: E V Schlyakhto, et al.
Published: (2022-01-01) -
Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
by: Runkai Li, et al.
Published: (2023-05-01) -
Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function
by: N. V. Drobotya, et al.
Published: (2020-05-01) -
Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01)